Money Info Show
Investment News Show on
Where To Invest January 2016
The January 12, 2015 Where To Invest In January 2016 Investment News Show features live interviews with:
Tim Connolly of Texas Gulf Oil TexasGulfOil.com on
Texas oil investing news
and
Gary Cella, Private Investor Radio Host
and
Dr Gloria Herndon with Immune Therapeutics Inc. (Stock Symbol: IMUN),
and
Melvin P. Foote, CEO & President Of Constituency for Africa (CFA-Network.org)
Hear a replay of Part 1 of the show with Tim Connolly and Gary Cella:
Hear a replay of Part 2 of the show with Gloria Herndon and Mel Foote:
About Melvin Foote and Constituency for Africa
Constituency for Africa website: CFA-Network.org
On Facebook: https://www.facebook.com/Constituency-for-Africa-347822291974589
Constituency for Africa is an advocate of the unity of all the different African-focused groups in the Western hemisphere especially in America.
Over the past twenty-four years, CFA has established itself as one of the leading organizations in the United States committed to educating and mobilizing the U.S. public on matters pertaining to Africa and the African Diaspora. As a result, CFA has done much to increase the level of cooperation and coordination among a broad-based coalition of international organizations, businesses and individuals committed to the progress, development, and empowerment of Africa and African people. In addition, CFA’s stellar achievement in advocacy education and information dissemination has led to a greater understanding and awareness of Africa among all groups.
CFA has pioneered a highly touted series of Town Hall Meetings on Africa, which have taken place in many cities and towns across the United States to better understand African policy issues and to actively participate in the policy formulation process. CFA also organizes the Ronald H. Brown African Affairs Series, held each year in September in Washington, D.C., which coincides with the Congressional Black Caucus (CBC) Annual Legislative Conference. The Series has continued to serve as a unique platform for linking the CBC members and their staff with African-focused organizations, African diplomats and government policy-makers, and the leadership of the grassroots community.
Melvin P. Foote, CEO & President
Mr. Melvin P. Foote is a pioneer in the field of African Affairs. He has over 35 years of experience and has worked in over 30 African countries. And he is recognized as a leading expert on issues related to African policies and programs.
Mr. Foote founded the Constituency for Africa (CFA) in 1990, in order to establish a network of organizations, groups and individuals committed to the progress and empowerment of Africa and African people worldwide. CFA’s mission is to build public and private support for Africa, and to help shape a progressive U.S. policy towards Africa.
Mr. Foote is also the founder of a dynamic CFA-related program called the African American Unity Caucus (AAUC). The AAUC is a broad-based coalition of African-American and African leaders of Africa-focused organizations and groups, to promote pan-Africanism and to link Diaspora leaders in the Western Hemisphere with the African Union (AU), the coordinating forum of the nations of Africa. Further, Mr. Foote serves as an advisor to the African Union’s Ambassador to Washington and as a consultant to the World Bank on African Diaspora issues.
About Immune Therapeutics Inc.
(Stock Symbol: IMUN)
Visit The Corporate Site — ImmuneTherapeutics.com
See Corporate Investors Information and stock quote page: Click Here
Immune Therapeutics is a specialty pharmaceutical company involved in the manufacturing, distribution and marketing of our novel patented therapies to combat chronic, life-threatening diseases through the activation and modulation of the body’s immune system. The Company’s technology platform is built on two different immunotherapies, Low Dose Naltrexone (LDN) and Methionine-Enkephalin (MENK).
Both therapies have been decades in the making at institutions such as the Pennsylvania State University Medical School at Hershey, University of Chicago, State University of New York, and Multiple Sclerosis Center at UCSF. These efforts were pioneered by leading immunologists: Dr. Nicholas Plotnikoff, Dr. Ronald Herberman, Dr. Bernard Bihari, Ian S. Zagon, Dr. Jill Smith, Patricia McLaughlin, and Dr. Jaquelyn McCandless.
Immune Therapeutics has spent the last two years acquiring regulatory approval in emerging and developing nations for LDN marketed under the brand name Lodonal™. Lodonal™ is a highly innovative immunotherapy for the treatment of autoimmune diseases, HIV/AIDS, opportunistic infections, cancer and a range of other serious diseases. Our proprietary Opiate and T Cell Receptor technology exploits the power of the body’s own immune system to find and kill diseased cells.
LDN (Low Dose Naltrexone)
Low Dose Naltrexone used as an immune modulator
Low Dose Naltrexone as it is known in the United States, or Lodonal as it is known internationally, has its origins in the FDA approved 50mg Naltrexone. Originally used to treat opiate dependences, the Immune Therapeutics patented treatments, which cover a wide range of indications (link to LDN patents), is currently used as an immune modulator. See Report — Click Here
About Tim Connolly and Texas Gulf Oil
Texas Gulf Oil & Gas Inc.’s operations philosophy combines its key executives’ deep roots in the oil and gas industry with an experienced and efficient investment management team. We base our approach to development opportunities on facts and sound production history, operating solely in proven oil production areas with long term potential. Our extensive local market knowledge combined with experienced technology professionals is the backbone of our operations model. Texas Gulf Oil & Gas Inc. is primarily focused on oil and gas production, maximizing the value of currently underutilized production resources in the targeted area.
Tim Connolly – Chairman, CEO, and founder of Texas Gulf Oil & Gas. Mr. Connolly is also the Managing Director and Founder of Corporate Strategies LLC, a private merchant banking firm based in Houston, Texas since 1984. Corporate Strategies portfolio companies have included interests in energy, technology, software development, defense electronics manufacturing, international nutritional products manufacturing and distribution, mobile device application development and other market segments, domestically and internationally. Mr. Connolly has personally completed over $1 billion in transactions as principal, broker or adviser to banks, hedge funds, and investment partnerships both domestically and overseas.
About Gary Cella, Private Investor and Investment news Show Host
A private investor from Greenwich CT, Gary is an investment news radio, TV and podcast host.
His investing and business areas of interest are primary in Medical, Oil and Gas and Manufacturing.
Contact Gary at: itsgmc@outlook.com
Or visit his website: GaryCella.com
Money Info
Investment News Show
Money Info Show Airs
10 AM to 11 AM EDT
Every Tuesday
Be On The Air With Us
Call In Your Questions
888-792-1590
The Princeton Research Money Info show features where to invest now, stock market, business, economy and financial investment news.
The show is broadcast live on the internet and on the air from the studios of Radio Station WPSL AM 1590, Port St. Lucie, Florida — The Talk of the Treasure Coast
Money Info is hosted by investing experts Mike King and Charles Moskowitz together with radio broadcasting professional Greg Wyatt.
